Publication Name	World Journal of Clinical Cases
Manuscript ID	79931
Country	Greece

Received	2022-09-12 10:32
Peer-Review Started	2022-09-12 10:34
First Decision by Editorial Office Director	2022-11-15 08:11
Return for Revision	2022-11-15 15:24
Revised	2022-11-23 09:35
Publication Fee Transferred
Second Decision by Editor	2022-12-27 03:09
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2022-12-27 09:55
Articles in Press	2022-12-27 09:55
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-12-28 06:34
Publish the Manuscript Online	2023-01-12 07:20

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Minireviews
Article Title	Liver function in transgender persons: Challenges in the COVID-19 era
Manuscript Source	Invited Manuscript
All Author List	Charalampos Milionis, Ioannis Ilias and Eftychia Koukkou
Funding Agency and Grant Number
Corresponding Author	Ioannis Ilias, MD, PhD, Consultant Physician-Scientist, Endocrinology, Diabetes and Metabolism , Elena Venizelou Hospital, 2, El. Venizelou Sq., Athens GR-11521, Greece. iiliasmd@yahoo.com
Key Words	Transgender persons; Drug induced liver injury; COVID-19
Core Tip	Transgender persons may account for approximately up to 0.3% of the population. Their access to health care and medications may be hampered in the coronavirus disease 19 (COVID-19) era. The effects of COVID-19 per se on the liver may not be negligible. In this concise review we ponder on these effects, honed on transgender persons.
Publish Date	2023-01-12 07:20
Citation	Milionis C, Ilias I, Koukkou E. Liver function in transgender persons: Challenges in the COVID-19 era. World J Clin Cases 2023; 11(2): 299-307
URL	https://www.wjgnet.com/2307-8960/full/v11/i2/299.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i2.299

Full Article (PDF)	WJCC-11-299.pdf
Full Article (Word)	WJCC-11-299.docx
Manuscript File	79931_Auto_Edited-JLW.docx
Answering Reviewers	79931-Answering reviewers.pdf
Audio Core Tip	79931-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	79931-Conflict-of-interest statement.pdf
Copyright License Agreement	79931-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	79931-Language certificate.pdf
Peer-review Report	79931-Peer-review(s).pdf
Scientific Misconduct Check	79931-Bing-Liu GL-2.png
Scientific Editor Work List	79931-Scientific editor work list.pdf
CrossCheck Report	79931-CrossCheck report.pdf